Marine sponge drug extends breast cancer survival: study

Jun 06, 2010

A new agent derived from a marine sponge can extend the survival rates of women with locally recurrent or metastatic breast cancer who already recieved extensive standard therapy, a new study unveiled Sunday found.

The synthetic component called eribulin mesylate mimics a component found naturally in sponges and can prevent cell devision, which causes cells to self-destruct, said study authors who presented their findings at the annual American Society of Clinical conference in Chicago.

In a randomized international trial, British researchers assessed the survival rates of 762 patients, treated either with eribulin or another therapy, almost always , and found the new therapy extended median overall survival by about 2.5 months.

"Until now, there hasn't been a standard treatment for women with such advanced . For those who have already received all of the recognized treatments, these are promising results," said lead study author Christopher Twelves.

"These findings may establish eribulin as a new, effective option for with heavily pre-treated metastatic breast cancer," said Twelves, head of the Clinical Cancer Research Groups at the Leeds Institute of Molecular Medicine in Britain.

Explore further: Taking the guesswork out of cancer therapy

add to favorites email to friend print save as pdf

Related Stories

Study: Radiation boosts prostate cancer survival

Jun 06, 2010

(AP) -- Doctors are reporting a key advance in treating men with cancer that has started to spread beyond the prostate: survival is significantly better if radiation is added to standard hormone treatments.

Second lumpectomy for breast cancer reduces survival rates

Oct 02, 2008

A majority of women with breast cancer today are candidates for lumpectomy, allowing for conservation of most of their breast tissue. Results of a UC Davis study, however, show that a number of women whose cancer recurs in ...

Recommended for you

Taking the guesswork out of cancer therapy

1 hour ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

2 hours ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

2 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

Computer model reveals cancer's energy source

4 hours ago

(Medical Xpress)—A computer model study reveals – for the first time – details of an energy-creating process vital and unique to cancer cells. The research holds promise for new interventions and for ...

User comments : 0